Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Am J Pharm Educ
2018 Mar 01;822:6083. doi: 10.5688/ajpe6083.
Show Gene links
Show Anatomy links
The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education.
Fernandes JPS
.
???displayArticle.abstract???
Objective. To show why medicinal chemistry must be a key component of the education of pharmacy students, as well as in the pharmacist's practice. Findings. Five case reports were selected by their clinically relevant elements of medicinal chemistry and were explained using structure-activity relationship data of the drugs involved in the case easily obtained from primary literature and in medicinal chemistry textbooks. Summary. This paper demonstrates how critical clinical decisions can be addressed using medicinal chemistry knowledge. While such knowledge may not explain all clinical decisions, medicinal chemistry concepts are essential for the education of pharmacy students to explain drug action in general and clinical decisions.
Alsharif,
Instructional model to teach clinically relevant medicinal chemistry.
2006, Pubmed
Alsharif,
Instructional model to teach clinically relevant medicinal chemistry.
2006,
Pubmed
Beleh,
Integrating a new medicinal chemistry and pharmacology course sequence into the PharmD curriculum.
2015,
Pubmed
Boatwright,
Legal aspects of expanded prescribing authority for pharmacists.
1998,
Pubmed
Burns,
A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
2000,
Pubmed
Cheng,
Paradoxic excitation with diphenhydramine in an adult.
1997,
Pubmed
Cunnane,
Psychosis with propranolol: still not recognized?
1987,
Pubmed
Eggleston,
Understanding allergic reactions to local anesthetics.
1996,
Pubmed
García-Gavín,
Allergic contact dermatitis caused by tetracaine contained in otic drops.
2011,
Pubmed
Garza,
Prophylaxis of migraine.
2006,
Pubmed
Giménez,
Evaluation of blockbuster drugs under the rule-of-five.
2010,
Pubmed
Hanukoglu,
Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis.
1992,
Pubmed
Holbrook,
Statin-associated rhabdomyolysis: is there a dose-response relationship?
2011,
Pubmed
Iqbal,
Akathisia: problem of history or concern of today.
2007,
Pubmed
Kalveram,
Experimental animal study of the allergenicity of tetracaine.
1978,
Pubmed
Kawane,
Aspirin-induced asthma and artificial flavors.
1994,
Pubmed
Khan,
Medicinal chemistry and the pharmacy curriculum.
2011,
Pubmed
Kubo,
Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay.
1987,
Pubmed
Law,
DrugBank 4.0: shedding new light on drug metabolism.
2014,
Pubmed
Liu,
Predicting blood-brain barrier penetration of drugs by microemulsion liquid chromatography with corrected retention factor.
2008,
Pubmed
Maier,
Sunscreens - which and what for?
2005,
Pubmed
Nicholls,
Rosuvastatin and progression of atherosclerosis.
2008,
Pubmed
Pfefferkorn,
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors.
2007,
Pubmed
Pharmacist Prescribing Task Force,
Prescribing by pharmacists: information paper (2009).
2010,
Pubmed
Prince,
Respiratory arrest following first dose of timolol ophthalmic solution.
1983,
Pubmed
Steffensmeier,
Do randomized controlled trials always trump case reports? A second look at propranolol and depression.
2006,
Pubmed
Szabadi,
Akathisia--or not sitting.
1986,
Pubmed
Tomoyasu,
Allergic reactions to local anesthetics in dental patients: analysis of intracutaneous and challenge tests.
2011,
Pubmed
Tonna,
Pharmacist prescribing in the UK - a literature review of current practice and research.
2007,
Pubmed
Tucker,
Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents.
1975,
Pubmed
Weijtens,
Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate.
2002,
Pubmed
Westerlund,
Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
1985,
Pubmed
White,
A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin.
2002,
Pubmed
Zimmerman,
The beta-adrenergic blocking agents and the treatment of glaucoma.
1979,
Pubmed
